Questions: Apoptosis and Programmed Cell Death

Question 1

A cancer cell overexpresses Bcl-2, an anti-apoptotic protein. How does this contribute to tumor development?

• A. Bcl-2 overexpression accelerates the cell cycle, causing the cancer cell to divide faster
• B. Bcl-2 overexpression blocks Bax/Bak pore formation in the mitochondrial membrane, preventing cytochrome c release and disabling the intrinsic apoptotic pathway
• C. Bcl-2 overexpression activates executioner caspases constitutively, forcing the cell into continuous apoptotic signaling
• D. Bcl-2 overexpression inhibits death receptors on the cell surface, blocking the extrinsic pathway only

Answer: (B)

Bcl-2 is an anti-apoptotic protein that blocks Bax and Bak from oligomerizing in the outer mitochondrial membrane — the step that would form pores and release cytochrome c. Cytochrome c release is the critical commitment step of the intrinsic pathway: once released, cytochrome c forms the apoptosome with Apaf-1, activating caspase-9 and then executioner caspases. By blocking this step, Bcl-2 overexpression allows cells with DNA damage or other pro-death signals to survive instead of undergoing apoptosis. Accumulated mutations in these surviving cells drive malignancy. This is why Bcl-2 was discovered as an oncogene in follicular lymphoma — its overexpression is not about growth acceleration but about evading the cell's own kill switch.

Question 2

Which feature of apoptosis distinguishes it most fundamentally from necrosis in terms of its effect on surrounding tissue?

• A. Apoptosis is faster than necrosis, so surrounding cells have less time to respond
• B. Apoptosis produces apoptotic bodies that are phagocytosed before their contents leak, preventing inflammation; necrosis causes membrane rupture and release of intracellular contents, triggering inflammation
• C. Apoptosis only affects individual cells, while necrosis always affects multiple cells simultaneously
• D. Apoptosis is triggered by viral infection, while necrosis is triggered by physical damage

Answer: (B)

The defining feature of apoptosis relative to necrosis is its orderly, contained nature. In apoptosis, the cell dismantles itself from the inside: it fragments its own DNA, condenses its chromatin, collapses its nuclear envelope, and packages its contents into membrane-bound apoptotic bodies. These bodies display 'eat me' signals (phosphatidylserine on the outer membrane leaflet) that recruit macrophages and neighboring cells for phagocytosis — all before any intracellular contents leak. Necrosis is the opposite: uncontrolled cell death causes membrane rupture, spilling cytoplasmic contents (damage-associated molecular patterns, DAMPs) into the extracellular space and triggering a potent inflammatory response. This distinction is clinically critical — apoptosis is physiologically normal and non-inflammatory; necrosis drives pathological inflammation.

Question 3

Apoptosis and necrosis are both forms of cell death, and both trigger inflammatory responses in surrounding tissue.

• T. True
• F. False

Answer: False

False. This is the central distinction between the two modes of cell death. Apoptosis is a programmed, orderly process that produces membrane-bound apoptotic bodies phagocytosed before their contents escape — no intracellular material enters the extracellular space, and therefore no inflammatory response is triggered. Necrosis is uncontrolled cell death (from toxins, physical trauma, ischemia) that ruptures the plasma membrane, releasing intracellular contents (including damage-associated molecular patterns) that activate the innate immune system and drive inflammation. Many diseases involve pathological necrosis-driven inflammation. Apoptosis, by contrast, is routinely used in development (sculpting digits, eliminating neurons that fail to find targets) without any inflammatory consequences.

Question 4

Executioner caspases (caspase-3 and caspase-7) are activated downstream of both the intrinsic (mitochondrial) and extrinsic (death receptor) apoptosis pathways.

• T. True
• F. False

Answer: True

True — convergence on executioner caspases is a defining feature of the apoptotic machinery. The extrinsic pathway activates initiator caspase-8 via death receptor signaling; the intrinsic pathway activates initiator caspase-9 via the apoptosome. Despite these different initiators and upstream signals, both pathways ultimately activate caspase-3 and caspase-7 — the executioner caspases that carry out the actual demolition: cleaving structural proteins, activating endonucleases to fragment DNA, collapsing the nuclear lamina, and triggering the 'eat me' phosphatidylserine flip. This convergence ensures that apoptosis, regardless of the triggering signal, produces the same orderly, non-inflammatory outcome.

Question 5

Why does apoptosis not trigger an inflammatory response the way necrosis does, and why is this distinction clinically important?

Model answer: Apoptosis avoids inflammation because the dying cell packages itself into membrane-bound apoptotic bodies before any intracellular contents can escape. Executioner caspases flip phosphatidylserine to the outer plasma membrane leaflet as an 'eat me' signal, recruiting macrophages and neighboring cells to phagocytose the apoptotic bodies while they are still intact. No damage-associated molecular patterns (DAMPs), cytoplasmic proteins, or DNA fragments are released into the extracellular space, so the innate immune system is not activated. Necrosis, by contrast, ruptures the plasma membrane, releasing all intracellular contents as DAMPs that strongly activate innate immunity and inflammation. Clinically, this distinction matters because: (1) apoptosis can eliminate billions of immune and epithelial cells daily without triggering autoimmune responses; (2) pathological necrosis (in myocardial infarction, stroke, or liver injury) drives the inflammatory damage that often exceeds the primary injury in severity; and (3) cancer therapies that induce necrosis (rather than apoptosis) can cause harmful inflammatory side effects.

The clean, phagocytosis-dependent clearance of apoptotic bodies is sometimes called 'efferocytosis' — it is so important for preventing inflammation that defects in efferocytosis are themselves linked to autoimmune diseases like lupus, where inadequately cleared apoptotic debris triggers self-directed immune responses.